CRGX — CARGO Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $219.57m
- -$32.99m
- 42
- 38
- 21
- 24
Annual cashflow statement for CARGO Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -5.85 | -41 | -98.1 | -168 |
| Depreciation | ||||
| Non-Cash Items | 0.507 | 7.47 | 11.1 | 14.9 |
| Unusual Items | ||||
| Purchased R&D | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 0.254 | 2.97 | 2.21 | 5.77 |
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Cash from Operating Activities | -4.94 | -29.1 | -81.2 | -140 |
| Capital Expenditures | -0.442 | -2.72 | -8.28 | -4.45 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | 0 | -0.558 | -0.715 | -301 |
| Sale of Fixed Assets | ||||
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Cash from Investing Activities | -0.442 | -3.28 | -8.99 | -305 |
| Financing Cash Flow Items | 0 | 0.232 | -5.47 | -0.593 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 5.41 | 34.2 | 495 | 103 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 0.03 | 1.83 | 404 | -341 |